1. Home
  2. PD vs EBS Comparison

PD vs EBS Comparison

Compare PD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$6.87

Market Cap

532.7M

Sector

Technology

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.10

Market Cap

466.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
EBS
Founded
2009
1998
Country
United States
United States
Employees
1155
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
532.7M
466.9M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
PD
EBS
Price
$6.87
$8.10
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$12.63
$12.00
AVG Volume (30 Days)
1.9M
614.2K
Earning Date
05-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
125.83
EPS
1.87
0.07
Revenue
$492,546,000.00
$742,900,000.00
Revenue This Year
$3.58
$1.29
Revenue Next Year
$2.88
N/A
P/E Ratio
$3.74
$116.79
Revenue Growth
5.36
N/A
52 Week Low
$5.70
$5.62
52 Week High
$17.45
$14.06

Technical Indicators

Market Signals
Indicator
PD
EBS
Relative Strength Index (RSI) 51.16 43.90
Support Level $6.01 $7.73
Resistance Level $7.91 $8.95
Average True Range (ATR) 0.39 0.55
MACD -0.02 -0.07
Stochastic Oscillator 37.55 27.17

Price Performance

Historical Comparison
PD
EBS

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: